Accepted at 4:18 a.m. Nov, 01, 2023 by Ahmed7
Author: Jwill
Co-authors: Ahmed7
Related Note: 1474340640502
Rationale for change

Added Sketchy Referance. (Copied from other card)
Source: Other - Sketchy

Sketchy Sketchy
Text
{{c2::Warfarin::Drug}} inhibits the enzyme {{c1::epoxide reductase}}
Extra
- AKA coumadin

- ↓ activation of vitamin K → ↓ levels of factors II, VII, IX, X and protein C and S
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy Extra
Empty field
Picmonic
Empty field
Physeo



OME

Additional Resources
One by one
Empty field
Changed Tags
#AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin
#AK_Step1_v12::#Physeo::05_Biochem::05_Metabolism::41_Vitamin_K_-_Nutrition #AK_Step1_v12::#AMBOSS::0OaeIk #AK_Step1_v12::#UWorld::#UWSA1 #AK_Step1_v12::#Bootcamp::Biochemistry::12_Vitamins::06_Vitamin_K_Clinical_Implications #AK_Step1_v12::^Systems::Respiratory::Pathology #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::20_Hereditary_thrombophilias::*Protein_C_S_Deficiency !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-Hematology #AK_Step1_v12::#AMBOSS::lQavw4 #AK_Step1_v12::#UWorld::Step::6477 #AK_Step1_v12::#Pixorize::01_Biochemistry::01_Vitamins::20_Vitamin_K_Biochemistry #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::05_Thrombophilias #AK_Step1_v12::#Pathoma::04_Hemostasis::04_Thrombosis #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::09_Vitamin_K_Dependent_Coagulation_Factors #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::03_Heparin_vs_warfarin::*Warfarin #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Original_Decks::Step_1::Zanki_Pharmacology !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step2_v12::Original_decks::Dorian::im::uw::heme/onc #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#B&B::11_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation